(Q40926289)

24 September 2017

The safety of intravenous iron dextran in hemodialysis patients (English)

1 reference

24 September 2017

Fishbane S

1

1 reference

24 September 2017

Ungureanu VD

2

1 reference

24 September 2017

Maesaka JK

3

1 reference

24 September 2017

Kaupke CJ

4

1 reference

24 September 2017

Lim V

5

1 reference

24 September 2017

Wish J

6

1 reference

24 September 2017

language of work or name

1 reference

1 October 1996

1 reference

American Journal of Kidney Diseases

24 September 2017

1 reference

24 September 2017

28

1 reference

24 September 2017

4

1 reference

24 September 2017

529-534

1 reference

Correction of the anemia of end-stage renal disease with recombinant human erythropoietin. Results of a combined phase I and II clinical trial

24 September 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2896%2990463-1

7 January 2021

Intravenous Iron Dextran in Clinical Medicine

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2896%2990463-1

7 January 2021

Reduction in recombinant human erythropoietin doses by the use of chronic intravenous iron supplementation

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2896%2990463-1

7 January 2021

The utility of zinc protoporphyrin for predicting the need for intravenous iron therapy in hemodialysis patients

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2896%2990463-1

7 January 2021

Structure of an iron-dextran complex.

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2896%2990463-1

7 January 2021

Valency Investigations of Iron Dextran (‘Imferon’)

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2896%2990463-1

7 January 2021

10.1016/S0272-6386(96)90463-1

Identifiers

DOI

1 reference

24 September 2017

1 reference